New initiative to lead industry innovation, social impact through AI

A collaboration between Cornell and r4 Technologies will develop and apply artificial intelligence solutions to structural challenges that have hindered growth and modernization, and will train a new generation of students to thrive in a data-driven world.

High body fat increases breast cancer risk for women with normal BMI

Postmenopausal women with higher levels of body fat have a significantly increased risk of developing breast cancer even if they have a normal body mass index, according to a new study.

Law, business students develop AI apps to aid nonprofits

A new class, Delivering Legal Services Through Technology, combined hands-on technical training with a speaker series to provide LL.M., J.D. and MBA students with both the broader context and the technological know-how they’ll need in an evolving field.

Gift funds new music professorship, supports wind symphony

Barbara and Richard T. Silver ’50, MD ’53 Professorship in the Department of Music and the Barbara and Richard T. Silver ’50, MD ’53 Wind Symphony are recent gifts.

Ibrahim named Weill Cornell Medicine dean for diversity and inclusion

Dr. Said Ibrahim has been appointed the inaugural senior associate dean for diversity and inclusion at Weill Cornell Medicine, effective Jan. 2.

Study reveals new role for methotrexate in fighting cancer

A study of the dual pathways that process the essential vitamin folate unexpectedly revealed a new way the cancer drug methotrexate works and may suggest strategies to boost its cancer-killing effects.

ILR announces 2019 Groat and Alpern award recipients

Carolyn Richmond ’91 and Diane Rosen ’78, will be honored with the ILR School’s 2019 Groat and Alpern Awards ceremony April 11.

ILR program helps people with criminal records return to workforce

Through the Criminal Justice and Employment Initiative, School of Industrial and Labor Relations legal experts are helping people with criminal records get jobs.

Weill Cornell Medicine awarded $9M grant for lymphoma research

Weill Cornell Medicine has been awarded a five-year, $9 million Program Project Grant from the National Cancer Institute to study an aggressive and incurable form of lymphoma.